P92-18271-04148
3 vaccinations
3 coded responses
27 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 018 / MA
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Registered in v-safe
-
2021-04-23
Dose 1 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-07
-
2021-05-14
Dose 2 — Pfizer-BioNTech
- 2021-05-14
-
2021-05-15
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-16
Survey response — days 1–6 daily, dose 2MedDRA: Nasal congestion — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-17
Survey response — days 1–6 daily, dose 2MedDRA: Cough, Nasal congestion — Feeling: Good · Site: Pain, Redness · HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-08-13
-
2021-11-12
Survey response — 6 month, dose 2MedDRA: Office visit, Postmenopausal haemorrhage — Feeling: Fair · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2021-11-12
Report sent to call center — 6 month, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-11-15
- 2021-11-19
-
2022-01-25
Dose 3 — Pfizer-BioNTech
- 2022-05-03
- 2022-07-26
- 2023-01-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-14 | Pfizer-BioNTech | |
| 3 | 2022-01-25 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-11-12 | Unsuccessful |
Free text
Release 8
Systemic reaction (other): Nasal congestion
Systemic reaction (other): Nasal congestion, cough
Release 10
Symptoms: Heavy post menopausal bleeding. Hadn't had a period in 23 months then did for 10 days. Will have d&c in 11 days.
Healthcare visit (other): GYN visit
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Postmenopausal haemorrhage | · | · | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release